Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for SRx Health Solutions (SRXH) over the last 8 years, with Q2 2025 value amounting to $13.3 million.

  • SRx Health Solutions' Cash from Investing Activities rose 39576.84% to $13.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $13.4 million, marking a year-over-year increase of 39735.61%. This contributed to the annual value of -$18000.0 for FY2023, which is 9090.91% up from last year.
  • Per SRx Health Solutions' latest filing, its Cash from Investing Activities stood at $13.3 million for Q2 2025, which was up 39576.84% from -$1.1 million recorded in Q1 2025.
  • In the past 5 years, SRx Health Solutions' Cash from Investing Activities ranged from a high of $13.3 million in Q2 2025 and a low of -$4.5 million during Q2 2024
  • Its 5-year average for Cash from Investing Activities is $594428.6, with a median of -$46500.0 in 2021.
  • As far as peak fluctuations go, SRx Health Solutions' Cash from Investing Activities skyrocketed by 3375000.0% in 2024, and later plummeted by 3746666.67% in 2025.
  • SRx Health Solutions' Cash from Investing Activities (Quarter) stood at -$229000.0 in 2021, then soared by 96.07% to -$9000.0 in 2022, then increased by 11.11% to -$8000.0 in 2023, then surged by 33750.0% to $2.7 million in 2024, then surged by 393.31% to $13.3 million in 2025.
  • Its Cash from Investing Activities was $13.3 million in Q2 2025, compared to -$1.1 million in Q1 2025 and $2.7 million in Q4 2024.